Brainstorm Cell Therapeutics Inc BCLI:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 11:22 AM EDT
3.97quote price arrow up+0.02 (+0.51%)
Volume
118,806
52 week range
2.92 - 17.95

...

Loading . . .
  • Open3.96
  • Day High4.06
  • Day Low3.93
  • Prev Close3.95
  • 52 Week High17.95
  • 52 Week High Date10/09/20
  • 52 Week Low2.92
  • 52 Week Low Date05/11/21

Key Stats

  • Market Cap144.19M
  • Shares Out36.32M
  • 10 Day Average Volume0.42M
  • Dividend-
  • Dividend Yield-
  • Beta0.02
  • YTD % Change-11.82

KEY STATS

  • Open3.96
  • Day High4.06
  • Day Low3.93
  • Prev Close3.95
  • 52 Week High17.95
  • 52 Week High Date10/09/20
  • 52 Week Low2.92
  • 52 Week Low Date05/11/21
  • Market Cap144.19M
  • Shares Out36.32M
  • 10 Day Average Volume0.42M
  • Dividend-
  • Dividend Yield-
  • Beta0.02
  • YTD % Change-11.82

RATIOS/PROFITABILITY

  • EPS (TTM)-0.94
  • P/E (TTM)-4.23
  • Fwd P/E (NTM)-4.84
  • EBITDA (MRQ)-30.074M
  • ROE (MRQ)-134.30%
  • Revenue (MRQ)0.00
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-
  • Debt To Equity (MRQ)0.00%

EVENTS

  • Earnings Date08/03/2021
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Brainstorm Cell Therapeutics Inc

There is no recent news for this security.

Profile

MORE
Brainstorm Cell Therapeutics Inc. is a biotechnology company. The Company is engaged in developing adult stem cell therapies for debilitating neurodegenerative disorders, such as Amyotrophic Lateral Sclerosis (ALS, also known as Lou Gehrig's disease), Multiple Sclerosis (MS) and Parkinson's disease (PD), among others. Its subsidiary, Brainstorm Cell Therapeutics Ltd. (the Israeli Subsidiary), holds rights to commercialize the technology, NurOwn. NurOwn is in clinical...
Jacob Frenkel Ph.D.
Chairman
Irit Arbel Ph.D.
Vice Chairman
Chaim Lebovits
Chief Executive Officer
Ralph Kern M.D.
President
David Setboun
Chief Operating Officer
Preetam Shah Ph.D.
Chief Financial Officer
Stacy Lindborg Ph.D.
Executive Vice President
Address
1325 Avenue of the Americas Fl 28
New York, NY
10019-6583
United States

Top Peers

SYMBOLLASTCHG%CHG
ONCS
OncoSec Medical Inc
3.99+0.04+1.01%
ENLV
Enlivex Therapeutics Ltd
9.63+0.08+0.84%
PSTI
Pluristem Therapeutics Inc
4.39+0.03+0.69%
CMPI
Checkmate Pharmaceuticals Inc
6.61-0.30-4.34%
PTN
Palatin Technologies Inc
0.6128+0.0046+0.76%